Skip to main content
. 2019 Nov 4;14(11):e0224073. doi: 10.1371/journal.pone.0224073

Fig 5. Evaluation of anti-CFA/I IgG and functional neutralizing antibodies against CFA/I+ ETEC (strain H10407).

Fig 5

Data are from d42 sera. (A) Geometric mean titers (+95% confidence interval) of log10 transformed of anti-CFA/I IgG Ab titers on d42 for all groups (n = 5/group); (B) Functional neutralizing antibodies against CFA/I+ ETEC strain H10407; bars represent the median ± ranges for each group (n = 5/group). Dotted horizontal line represents the limit of detection for the assays. *P<0.05, **P<0.01, and ***P<0.001 indicated for statistical comparisons performed within mLT or dmLT groups; #P<0.05, # #P<0.01, and # # #P<0.001 indicated for statistical comparisons performed between the same dose of mLT and dmLT.